-
Tonicity
NS?
- hypotonicity: 0.45% NS
- isotonicity: 0.9% NS
- hypertonicity: 3.0% NS
-
Gain of H2O:
hyponatremia
-
-
patho:
Addison’s disease
Decreased aldosterone secretion
Diuretics
Vomiting
Diaphoresis
Wounds
-
patho:
SIADH
Heart failure
Polydipsia/Hyperglycemia
Excess intake (IV, PO) fluids
-
patho:
Excessive PO Na+ intake
Decreased water intake
Sodium retention
hypernatremia
-
Gain of Na+
hypernatremia
-
Cushing’s Syndrome
Hyperaldosteronism
Renal Failure
Sodium retention
-
patho:
Diabetes Insipidus
Osmotic diuresis
Burns
Dehydration
Fever/infection
Diarrhea
hypernatremia
-
Loss of H2O
hypernatremia
-
Correct slowly (48 hours)
Prevent cerebral edema
Monitor Neuro
hypernatremia
-
Treat cause
Lasix (due to poor KF)
hypernatremia
-
Restore normal serum Na+ levels
Hypotonic IVF (0.225%)
hypernatremia
-
Nutrition
Na+ restriction
hypernatremia
-
Nutrition
Increase oral intake NaCl tabs
hyponatremia
-
Treat cause
Decrease loop diuretics
hyponatremia
-
Restore normal serum Na+ levels
Small volume hypertonic IVF (2%-3%) saline
hyponatremia
-
K+ regulation
- Renal
- Intracellular-extracellular shifts
-
pressure exerted by proteins in the blood plasma or interstitial fluid.
osmotic pressure
-
force generated by the pressure of fluid within capillary on the capillary wall.
Hydrostatic pressure
-
Sodium polystyrene sulfonate (Kayexalate) has been used as an oral or rectal therapy for
hyperkalemia
-
intercellular shifts of glucose is common for ___________.
hyperkalemia
-
β2-agonist(s) that has a stimulatory effect on Na+/K+ ATPase and the resultant intracellular shift of potassium
- Albuterol
- D50 + Insulin IV
-
Calcium Gluconate/Calcium Chloride prevents the deleterious cardiac effects of severe __________.
- hyperkalemia
- hypermagnesemia
-
clinical manifestation:
Acute weight loss
Increased ADH secretion
Increased serum osmolarity
Decreased vascular volume
fluid volume deficit
-
labs
Increased hematocrit
Increased BUN
(blood urea nitrogen)
Increased spec. gravity
fluid volume deficit
-
S/S
Decreased urine output
Tachycardia
Postural hypotension
Elevated temperature
Fluid Volume Deficit
-
Manifestations
Acute, rapid weight gain
Peripheral edema
Increased interstitial fluid
U/O- polyuria
Increase vascular volume
Fluid volume excess
-
Labs
Dilutional hyponatremia
Dilutional anemia
Hematocrit decreased
BUN decreased
Fluid volume excess
-
s/s
Dependent edema
Generalized edema
Pulmonary edema
Jugular Vein Distention
fluid volume excess
-
causes:
Diabetes Insipidus
Osmotic diuresis
Burns
Dehydration
Fever/infection
Diarrhea
-
causes:
Decreased water intake
Sodium retention
Cushing’s Syndrome
Hyperaldosteronism
Renal Failure
- hypernatremia
- increased Na+
-
HCO3- retention
loss of K+ & H+
- metabolic alkalosis
- hyperaldosterism
-
hypomagnesium
hypernatremia
- metabolic acidosis
- DM + ketabolic acidosis
-
causes
Diuretics
Alcoholism
GI
Laxative abuse
Hyperglycemia
DKA
HHNS
Gastric Suctioning
Massive Burns
hypomagnesemia
-
what causes decreased aldosterone secretion?
hyponatremia
-
Addison’s disease
Tx
hyponatremia
-
Hyperglycemia vs DKA
hyponatremia
-
-
-
low Hydrostatic Pressure
cause of edema
-
Venous Obstruction
- cause of edema -->
- hydrostatic pressure
-
low Capillary Colloidal Pressure
- cause of edema -->
- plasma proteins
-
Loss of plasma proteins
- cause of edema -->
- plasma proteins
-
Production of plasma proteins
cause of edema
-
high Vascular Volume
- cause of edema -->
- hydrostatic pressure
-
Ischemia & cell death/necrosis
edema
-
release of ______ results in efferent arteriole vasoconstriction.
renin
-
Release of renin results in ______ arteriole vasoconstriction.
efferent
-
vasoconstriction of the efferent arteriole in the kidneys results in __________.
increase in blood pressure
-
angiotensin II triggers _______ at the adrenal cortex
Aldosterone
-
angiotensin II triggers Aldosterone in the _______
adrenal cortex
-
aldosterone produces
1
2
3
- 1) efferent arterial blood pressure
- 2) increase in vascular volume due to vasoconstriction
- 3) Na+ retention
-
Na+ controls _______ fluid
extracellular
-
1.6 to 2.6 mg/dL
NORMALS for Mg+
-
135-145 mEq/L
NORMALS for Na+
-
3.5-5.0 mEq/L
NORMALS for Na+
-
-
-
-
anemia + hyperventiation
respiratory alkalosis
-
COPD + hypoventilation
respiratory acidosis
-
diuresis + hypernatremia
metabolic acidosis
-
hypokalemia
hypernatremia
diuresis
hyperaldosterism
metabolic alkalosis
-
hyponatremia + edema
SIADH
-
-
-
hypernatremia + polyruria
DI
-
what cause increased ADH secretion
fluid deficit
-
cushings syndrome
- hypernatremia
- hypokalemia
-
addison's disease
- hyponatremia
- Decreased aldosterone secretion
-
-
-
-
MAO:
inhibits human DNA
NRTI
-
bone marrow suppression
CP450
hepatotoxic
NRTI
-
-
Blocks integration of viral DNA
INSTI
-
there is one opportunity for this HIV drug to be effective
INSTI
-
attachment inhibitors
maraviroc
-
blocks HIV receptors so they cannot bind
attachment inhibitors
-
-
-
-
steven johnson syndrome HIV
NNRTI
-
-
internalization
fusion inhibitors
-
-
-
-
-
-
aldosterone vs ADH
increase Na+ vs increase H2O
-
Addisons vs Cushings
decrease Na+ vs increase Na+
-
indications for neuromuscular blockers
adjunct to anesthesia
-
blocks Ach --> nicotinicM receptors
Panuronium
-
panuronium
nonpolarizing neuromuscular blocker
-
polarizing neuromuscular blocker
succinycholine
-
agonist to nicotinicM receptors
succinylcholine
-
side effects of these drugs are that they trigger a histamne release, resulting in hypotension
neuromuscular blockers
-
Adverse effects
Headache
Reflex bradycardia
Reslessness and excitability
Phenylephrine
-
alpha 1 agonist
phenyephrine
-
Alpha 2 adrenergic receptors
Clonidine
-
inhibits norepinephrine
clonidine
-
Selectively activates alpha 2 receptors in CNS where autonomic regulation of C-V system occurs (brainstem)
clonidine
-
stimulates sympathetic outflow to blood vessels and heart is reduced
clonidine
-
BETA 1 Receptor
dobutamine
-
Stimulation results in:
increased heart rate, force, automaticity, conduction rates
lipolysis
renin release
dobutamine
-
positive inotropic
positive chronotropic
postive dromostropic
dobutamine
-
Used during and following cardiac surgery, CHF, low CO states, shock
Given IV
dobutamine
-
Contraindications:
Angina, CAD, heart monitor
dobutamine
-
Adverse effects
Tachycardia
Chest pain, hypotension
-
Stimulation results in:
Bronchodilitation
Vasodilitation
Slight decrease in peripheral resistance
Relaxation of pregnant uterus
Glycogenolysis
Release of glucagon
albuterol
-
Used to treat
asthma, bronchospasm, COPD, CHF, CF
albuterol
-
Nonselective adrenergic receptors
Epinephrine
-
Produces both alpha and beta effects
epinephrine
-
Used to Tx
shock, asthma, CP resuscitation, heart blocks, simple glaucoma, adjunct to topical anesthesia, anaphylactic shock, GI hemorrhag
epinephrine
-
Given topically, IM, Sub Q, IV
epinephrine
-
Wide ranging effects depending upon receptor
epinephrine
-
Contraindications
Hypersensitivity
narrow-angle glaucoma
labor
coronary insufficiency
epinephrine
-
contraindicated w/ ventricular dysrhythmias, diabetes, Parkinson’s disease, & uncorrected hypovolemia
epinephrine
-
agonist for alpha and beta 1
Norepinephrine
-
Alpha-Adrenergic Blockers
Phentolamine
-
non-selective adrenergic antagonists
phentolamine
-
Selective alpha 1 blockade
prazosin (minipress)
-
MAO: vasodilation
Tx: HTN
ADR: orthostatic hypotension
prazosin
-
-
cardioselective
metorolol
-
noncardioselective
propranolol
-
cardioselective only at therapeutic levels, at higher does will exhibit noncardioselectivity
metorolol
-
noncardioselective
propranolol
-
Used for BP and HR control
Used more often than alpha blockers
metorolol
-
May also have alpha blockade property even at therapeutic levels
metorolol
-
how much do e have to give to illicit a response
dose-response relationship
-
max efficacy
dose-response relationship
-
receptor activation intensity
dose-response relationship
-
relative potency
dose-response relationship
-
what does the drug do at the site of acton
drug-receptor interactions
-
simple vs modified occupied theory
drug-receptor interaction
-
RN is only person whose actions are not routinely checked by others. A few exceptions
A PINCH medications
-
Threshold for detecting response is reached
dose-response relationship
-
largest effect that a drug can produce
max efficacy
-
Indicated by height of Dose-Response curve
max efficacy
-
bigger doses unable to elicit a further increase in response
All receptors bound by drug
max efficacy
-
relative potency vs affinity
-
potency is a difference in _______ whereas efficacy is a difference in _________.
dose; response
-
*bigger doses unable to elicit a further increase in response
*All receptors bound by drug
simple occupancy
-
does not account for relative potency or max efficacy
simple occupancy
-
Reflected in drug’s maximal efficacy
*Intrinsic activity
-
Bind irreversibly to receptors
noncompetitive antagonists
-
Continual exposure to agonist
Desensitized; tolerance
-
down-regulation
desensitized; tolerance
-
Continual exposure to antagonist
Hypersensitivity
-
up-regulation
hypersensitivity
-
Dose required to produce a defined effect in 50% of population
ED50
-
movement of drug from blood to sites of action
Distribution
-
Drug molecules tend to accumulate on side where pH favors ionization
pH partitioning
-
Blood flow to tissues
distribution
-
movement across cell membranes
distribution
-
Polar, ionized, protein-bound= No
lipid-soluble yes
distribution
-
Drug movement at the capillary bed
distribution
-
Blood Brain Barrier
distribution
-
chemical reactions --> metabolites
Biotransformation
-
study of a single gene’s role in the client’s response to drugs
Pharmacogenetics
-
study of how genes affect a client’s response to drugs
Pharmacogenomics
-
absorption
first pass metobolism
bioavailability
-
Concentration gradient drives reabsorption of drug from lumen of tubule back into bloodstream
passive tubular reabsorption
-
Must be lipid soluble to cross tubular and vessel cell membranes
passive tubular reabsorption
-
Ionized and polar drugs remain in urine to be excreted
passive tubular reabsorption
-
Fluid & molecules move through capillary pores into tubular urine
glomerular filtration
-
Time required to eliminate 50% of total amount of drug in body
half life
-
An index of how rapidly a decline in drug occurs
half life
-
Reflection of metabolism and excretion
half life
-
The rate of drug eliminated depends on amount of drug present
half life
-
_______ of drug determines dosing intervals
Half life
-
Thiazide diuretics
- Hydrochlorothiazide (HCTZ)
- Chlorthalidone
-
MAO
Na+ excretion at distal tubs
Decrease GFR
blocks H2O reabsorption
-
USE
Hypernatremia
Hyper/Hypokalemia
-
Tx
Edema
HF
preferred drug
-
Adverse Effects
Hypokalemia/hyperglycemia
Hyponatremia/dehydration
Orthostatic HTN
-
DDI
NSAIDS→ Reduced diuresis with what drugs?
-
High-ceiling (loop) diuretic
Furosemide (Lasix)
-
MAO
Na+ excretion at ascending loop of Henle
furosemide (lasix)
-
USE
Hypernatremia
Hyperkalemia
Hypokalemia
2nd-line HTN
Edema
furosemide (Lasix)
-
diuretics indicated for renal impairment
furosemide (lasix)
-
diuretics contraindicated for Hyponatremia
furosemide
-
diuretics w ADR: ototoxicity
furosemide (loop)
-
NSAIDS = synergist to which diuretics
furosemide (lasix)
-
K+ Sparing diuretics
Spironolactone (Aldactone)
-
MAO
Aldosterone receptor antagonists
Prevent the re-absorption of Na+ @ the collecting duct
spironolactone (Aldactone)
-
USE
Combo w/ thiazides & loops
Effects are delayed
spironolactone (Aldactone)
-
Tx
Edema
spironolactone (Aldactone)
-
Adverse effects
Hyperkalemia
spironolactone (Aldactone)
-
diuretics that have Synergy w/
ACE inhibitors
ARBs
spironolactone (aldactone)
-
diuretics that are contraindicated with salt substitutes (KCl)
spironolactone (Aldactone)
-
Osmotic diuretics, Mannitol, may have ADR w/ what type fluid imbalance?
-
Treat cause
Decrease loop diuretics
HYPOnatremia
-
Tx
when would you use Diuretics (Lasix, HCTZ) w/ K+ sparing like Spironolactone?
hypokalemia
-
Only therapeutic use of irreversible agent
-
Bone marrow depression, which leads to aplastic anemia and neutropenia, would also be ADR for which type of HIV drug
NRTI
-
-
-
lactic acidosis ADR w/ HIV drug_____.
NRTI
-
Resistance: virus mutates gene encoding the glycoprotein è alters shape so drug can no longer bind
Fusion inhibitor
-
Reserved for patients who have failed more standard HAART (RTIs and PIs)
fusion inhibitors
-
only approved CCR5 antagonist
attachment inhibitor
-
SIADH vs DI
- increased H2O, ADH, & SG
- VS decreased H2O, ADH, & SG
-
the rate at which red blood cells sediment in a period of one hour.
erythrocyte sedimentation rate ESR
-
It is a common hematology test, and is a non-specific measure of inflammation.
ESR
-
high ESR indicates what
- acute infection
- inflammatory diseases
- blood cancers
|
|